Print

Robotic Surgery at JFK Helps Patients Avoid Chemotherapy

Michael Lasser, MD, Urologist, consults with robotic surgery patient Martin Joseph of Old Bridge, after prostate procedure.

Martin Joseph of Old Bridge wasn’t alarmed when he was told that his annual physical showed his PSA (prostate-specific antigen) was elevated from the year before. He went to see a urologist, who recommended a biopsy of his prostate.

The results of the biopsy showed several cancerous cells and, with a family history of prostate cancer on his mind, he sought out medical advice for his next steps. The options became clear; the tumors needed to be removed surgically or treated through chemotherapy.

“I knew people who had gone through chemotherapy, and knew of the side effects they had to deal with,” recalled Martin. “When the radiologist recommended robotic surgery, I did research and thought it sounded like a good option. I met with Dr. Michael Lasser, Medical Director, Robotic Surgery at JFK. He told me how fast people recuperated from the robotic surgery and I knew it was how I wanted to go.” Martin’s surgery was conducted at JFK Medical Center using the latest da Vinci Xi surgical system.

“I only had to stay in the hospital one night after my surgery,” noted Martin. “Afterward, it only took about two or three weeks before I was back to myself. My most recent PSA tests were back to normal. That’s what you call a successful surgery.”

JFK surgeons now use the latest da Vinci Xi surgical system, which is the newest addition to the da Vinci line of robotic surgery tools originally introduced in 2000.

Robotic surgery uses advanced robotic, computer and optical technologies to assist the surgeon with an operation. Its movements are completely controlled by the surgeon, but with 3D high definition vision systems, special instruments and computer software, the surgeon can operate with enhanced vision, precision, dexterity and control.

The inclusion of the latest in robotic surgery tools among JFK Medical Center’s surgical offerings is a reinforcement of the efforts to stay on the leading edge of treatment, ensuring that the JFK community receives the best care.